Clinical Application of Intact Parathyroid Hormone Assays

Berson SA Yalow RS Aurbach GD Potts JT . Immunoassay of bovine and human parathyroid hormone. Proc Natl Acad Sci USA 1963; 49: 613–7.

Papapoulos SE Manning RM Hendy GN Lewin IG O'Riordan JLH . Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clin Endocrinol 1980; 13: 57–67.

Manning RM Adami S Papapoulos SE Gleed JH Hendy GN Rosenblatt M . A carboxy-terminal specific assay for human parathyroid hormone. Clin Endocrinol 1981; 15: 439–49.

Mallette LE Tuma SN Berger RE Kirkland JL . Radioimmunoassay for the middle region of human parathyroid hormone using an homologous anti-serum with a carboxy terminal fragment of bovine parathyroid hormone as radioligand. J Clin Endocrinol Metab 1982; 54: 1017–24.

Nussbaum SR Zahradnik RJ Lavigne JR Brennan GL Nozawa-Ung K Kim LY . Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcaemia. Clin Chem 1987; 33: 1364–7.

Brown RC Aston JP Weeks I Woodhead JS . Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab 1987; 65: 407–14.

Lunberg PA Lindstedt G Jansson S Tisell LE . Assay of intact parathyrin in the immediate and long-term post operative follow-up of patients treated for hyperparathyroidism or thyroid tumour. Clin Chem 1989; 35: 340–1.

Wood PJ . The measurement of parathyroid hormone. Ann Clin Biochem 1992; 29: 11–21.

Fischer JA . Parathyroid hormone. In: Bronner F Coburn J , eds. Disorders of Mineral Metabolism. London Academic Press, 1982: 271–358.

Kronenberg HM Bringhurst FR Segre GV Potts JT . Parathyroid hormone biosynthesis and metabolism. In: Bilezikian JP Marcus R Levine MA , eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 125–37.

Newman DJ Ashby JP . Clinical and laboratory evaluation of a two-site immuno-radiometric assay for intact parathyroid hormone. Ann Clin Biochem 1988; 25: 654–60.

Toffaletti J Cooper DL Lobaugh B . The response of parathyroid hormone to specific changes in ionized calcium ionized magnesium, or protein bound calcium in humans. Metabolism 1991; 40: 814–8.

Rude RK . Parathyroid function in magnesium deficiency. In: Bilezikian JP Marcus R Levine MA , eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 829–42.

Kitamura N Shigeno C Shiomi K Lee K Ohta S Sone T . Episodic fluctuation in serum intact parathyroid hormone in men. J Clin Endocrinol Metab 1990; 70: 252–63.

Logue FC Fraser WD O'Reilly D StJ Beastall GH . The circadian rhythm of intact parathyroid hormone (1–84) and nephrogenous cyclic adenosine monophosphate in normal men. J Endocrinol 1989; 121: R1–R3.

Logue FC Fraser WD Gallacher SJ Cameron DA O'Reilly D StJ Beastall GH . The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism. Clin Endocrinol 1990; 32: 475–83.

Logue FC Beastall GH Fraser WD O'Reilly D StJ. Intact parathyroid hormone assays. Br Med J 1990; 300: 210–1.

Calvo MS Eastell R Offord KP Bergstralh EJ Burritt MF . Circadian variation in ionised calcium and intact parathyroid hormone: Evidence for sex differences in calcium homeostasis. J Clin Endocrinol Metab 1991; 72: 69–76.

Campbell GA Kemm JR Hosking DJ Boyd RV . How common is osteomalacia in the elderly? Lancet 1984; ii: 386–8.

Orrell DH . Albumin as an aid to the interpretation of serum calcium. Clin Chim Acta 1971; 35: 483–9.

Payne RB Little AJ Williams RB Milner JR . Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 1973; 4: 643–6.

Imrie CW Allam BF Ferguson JC . Hypocalcaemia in acute pancreatitis: The effect of hypoalbuminaemia. Curr Med Res Opinion 1976; 4: 101–16.

Barth JH Fiddy JB Payne RB . Adjustment of serum total calcium for albumin concentration: Effects of non-linearity and of regression differences between laboratories. Ann Clin Biochem 1996; 33: 55–8.

Ashby JP Wright DJ Rinsler MG . The adjusted calcium concept—a reappraisal. Ann Clin Biochem 1986; 23: 533–7.

Heath H Purnell DC . Asymptomatic hypercalcemia and primary hyperparathyroidism. In: Heath DA Marx SJ , eds. Calcium Disorders. London: Butterworth Scientific 1982: 189–216.

Fisken RA Health DA Somers S Bold AM . Hypercalcaemia in hospital patients. Clinical and diagnostic aspects. Lancet 1981; 1: 202–7.

Harrop JS Bailey JE Woodhead JS . Incidence of hypercalcaemia and hyperparathyroidism in relation to the biochemical profile. J Clin Pathol 1982; 35: 395–400.

Gardin JP Paillard M . Normocalcaemic primary hyperparathyroidism: Resistance to PTH effect on tubular reabsorption of calcium. Min Elect Metab 1984; 10: 301–8.

Broadus AE Horst RL Littledike ET Mahaffey JE Rasmussen H . Primary hyperparathyroidism with intermittent hypercalcaemia: Serial observations and differential diagnosis by means of an oral calcium tolerance test. Clin Endocrinol 1980; 12: 225–35.

Klugman VA Farns MJ Pak CYC . Nephrolithiasis in primary hyperparathyroidism. In: Bilezikian JP Marcus R Levine MA , eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 505–17.

Insogna KL Broadus AE . Nephrolithiasis. In: Felig P Baxter JD Broadus AE Froham LA , eds. Endocrinology and Metabolism. New York: McGraw-Hill 1987: 1500–77.

Heath H . Familial benign (hypocalciuric) hypercalcemia: A troublesome mimic of primary hyperathyroidism. Endocrinol Metab Clin North Am 1989; 18: 723–40.

Marx SJ Attie MF Levine MA Spiegel AM Downs RW Lasker RD . The hypocalciuric or benign variant of familial hypercalcaemia: Clinical and biochemical features in fifteen kindreds. Medicine 1981; 60: 397–412.

Stuckley BGA Kent GN Gutteridge DH Pullan PT Price RI Bhagat C . Fasting calcium excretion and parathyroid hormone together distinguish familial hypocalciuric hypercalcaemia from primary hyperparathyroidism. Clin Endocrinol 1987; 27: 525–33.

Gunn IR Wallace JR . Urine calcium and serum ionised calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia. Ann Clin Biochem 1992; 29: 52–8.

Heath DA . Familial hypocalciuric hypercalcaemia. In: Bilezikian JP Levine MA Marcus R , eds. The Parathyroids, Basic and Clinical Concepts New York: Raven Press, 1994: 699–710.

Firek AF Kao PC Heath H . Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: Greater responsiveness to endogenous PTH than in primary hyperparathyroidism. J Clin Endocrinol Metab 1991: 72: 541–6.

McMurtry CT Schranck FW Walkenhorst DA Murphy WA Kocher DB Teitelbaum SL , Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcaemia. Am J Med 1992; 93: 247–58.

Langman CB Budayr AA Sailer DE Strewler GJ . Non malignant expression of PTHRP is responsible for idiopathic infantile hypercalcemia. J Bone Mineral Res 1992; (suppl 1); S93.

Flentje D Schmidt-Gayk H Fischer S Stern J Blind E Buhr H , Intact parathyroid hormone in primary hyperparathyroidism. Br J Surg 1990; 77: 168–72.

Newman DJ Thakkar H Ashby JP . Clinical utility of region-specific assays in the investigation of hypercalcaemia. Ann Clin Biochem 1987; 24 (suppl 1): 150–1.

Blind E Schmidt-Gayk H Scharla S Flentje D Fischer S Gohring U , Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a mid-region assay. J Clin Endocrinol Metab 1988; 67: 353–60.

Aston P Wheeler MH Brown RC Curley IR Woodhead SJ . Laboratory comparison of diagnostic specificity of intact hormone and region-specific immunoassays of parathyroid hormone. World J Surg 1990; 14: 419–24.

Ljunghall S Larsson K Lindh E Lindquvst U Rastas J Akerstrom G . Disturbance of basal and stimulated intact parathyroid hormone in primary hyperparathyroidism. Surgery 1991; 110: 47–53.

Blind E Raue F Gotzmann J Schmidt-Gayk H Kohl B Zeigler R . Circulating levels of mid-regional parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol 1992; 37: 290–7.

Mundy GR Ibbotson KJ D'Souza SM . Tumor products and the hypercalcaemia of malignancy. J Clin Invest 1985: 76: 391–4.

Yoshimoto K Yamasaki R Sakai H Tezuka U Takahashi M I'Zuka M . Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 1989; 68: 976–81.

Nussbaum SR Gaz RD Arnold A . Hypercalcaemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 1990; 323: 1324–8.

Strewler GJ Budayr AA Clark OH Nissenson RA . Production of parathyroid hormone by a malignant non parathyroid tumour in a hypercalcaemic patient. J Clin Endocr Metab 1993; 76: 1373–5.

Suva LJ Winslow GA Wettenhall REH Hammonds RG Moseley JM Diefenbach-Jagger H . A parathyroid hormone-related protein implicated in malignant hypercalcaemia: Cloning and expression. Science 1987; 237: 893–6.

Boscato LM Stuart MC . Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32: 1491–5.

Clark PM Raggatt PR Price CP . Antibodies interfering in immunometric assays. Clin Chem 1985;31: 1762.

Cusick CF Mistry K Addison GM . Interference in a two-site immunoradiometric assay for thyrotropin in a child. Clin Chem 1985; 31: 348–9.

Hunter WM Budd PS . Circulating antibodies to ovine and bovine immunoglobulins in healthy subjects: A hazard for immunoassays. Lancet 1980; ii: 1136.

Mallette LE Nammour H . False positive elevations of midregion parathyroid hormone: Inhibition of radioligand binding by a heterophilic antibody in patient serum [Abstract 134]. In: Cohn DU Martin TJ Meunier PJ . Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects: Proceedings of 9th International Conference on Metabolism. Amsterdam, New York: Excerpta; Elsevier Science, 1987.

Wilkinson M McElduff A Wilson J Haber P Freeman A Robertson M . Spontaneously occurring antibodies to parathyroid hormone. J Clin Endocrinol Metab 1990; 70: 1744–9.

Kasono K Sato K Suzuki T Ohmura E Demura R Shizume K . Falsely elevated serum parathyroid hormone levels due to immunoglobulin G in a patient with idiopathic hypoparathyroidism. J Clin Endocrinol Metab 1991; 72: 217–22.

Ashby JP Loveridge N Brown RC Zanelli JM Rinsler MG Watts RWE . Anomalies in the assay of parathyroid hormone in normocalcaemic patients with renal stone disease. Clin Endocrinol 1988; 29: 131–40.

Lips P Netelenbos JC van Doom L Hackeng WHL Lips CJM . Stimulation and suppression of intact parathyroid hormone (PTH1–84) in normal and hyperparathyroid patients. Clin Endocrinol 1991; 35: 35–40.

Salazar J Dembrow V Egozi I . A review of 265 cases of parathyroid explorations. Am Surgeon 1986; 52: 174–6.

Statava RM Beahrs OH Scholz DA . Success rate of cervical exploration for hyperparathyroidism. Arch Surg 1975; 110: 625–8.

Doppman JL . Preoperative localisation of parathyroid tissue in primary hyperparathyroidism. In: Bilezikian JP Marcus R Levine MA , eds. The Parathyroids, Basic and Clinical Concepts. New York: Raven Press, 1994: 553–65.

Fine EJ . Parathyroid imaging: Its current status and future role. Sem Nucl Med 1987; 17: 350–9.

McKillop JH Boyle IT Gunn IG Hutchison JSF . Preoperative localisation of parathyroid adenomas. Scot Med J 1986; 31: 10–14.

Beastall GH McKellar N Boyle IT Joffe SN Hutchison JSF Boyce BF . Preoperative localisation of parathyoid tumours using neck vein catheterisation and radioimmunoassay for parathyroid hormone: The Glasgow experience. Scot Med J 1983; 28: 146–52.

Dunlop DAB Papapoulos SE Lodge RW Fulton AJ Kendall BE O'Riordan JLH . Parathyroid venous sampling: Anatomic considerations and results in 95 patients with primary hyperparathyroidsim. Br J Radiol 1980; 53: 183–91.

Brennan MF Doppman JL Kurdy AG Marx SJ Spiegel MM Auerbach GD . Assessment of techniques for preoperative parathyroid gland localisation in patients undergoing reoperation for hyperparathyroidism. Surgery 1982; 91: 6–11.

Young AE Gaunt JL Croft DN Collins RE Wells CP Coakley AJ . Localisation of parathyroid adenomas by Thallium-201 and Technetium-99m subtraction scanning. Br Med J 1983; 286: 1384–6.

Ferlin G Borsato N Camerani M Conte N Zotti D . New perspectives in localising enlarged parathyroid glands by Technetium-Thallium subtraction scan. J Nucl Med 1983; 24: 438–41.

Stewart AF Broadus AE . Mineral metabolism. In: Felig P Baxter JD Broadus AE Frohman LA , eds. Endocrinology and Metabolism. New York: McGraw-Hill, 1987: 1317–453.

Livingstone JI Tellez M Burke M Ashby PJ Rinsler MG . A five year audit of the role of parathyroid hormone assays and thallium-technetium isotype subtraction scanning in the preoperative investigation of primary hyperparathyroidism. Postgrad Med J 1991; 67: 1055–8.

Brasier AR Wang CA Nussbaum SR . Recovery of parathyroid hormone secretion after parathyroid adenomectomy. J Clin Endocrinol Metab 1988; 66: 495–500.

Nussbaum SR Thomson AR Hutcheson KA Gaz RD Wang C . Intraoperative measurement of parathyroid hormone in the surgical measurement of hyperparathyroidism. Surgery 1988; 104: 1121–7.

Ryan MF Jones SR Barnes AD . Intraoperative monitoring of parathyroid hormone levels using a rapid immunoradiometric assay method. Ann Clin Biochem 1990; 27: 65–8.

Ryan MF Jones SR Barnes AD . Clinical evaluation of a rapid parathyroid hormone assay. Ann Clin Biochem 1992; 29: 48–51.

Wilkinson H . Hyperparathyroidism. Ann Clin Biochem 1990; 27: 603.

Desai TK Carlson RW Geheb MA . Prevalence and clinical implications of hypocalcaemia in acutely ill patients in the medical intensive care setting. Am J Med 1988; 84: 209–14.

Chernow B Zaloga G McFadden E Clapper M Kotler M Barton M . Hypocalcemia in critically ill patients. Crit Care Med 1982; 10: 848–51.

Derasmo AU Celi FS Acc M Ministola S Aliberti G Mazzuroli GF . Hypocalcemia and hypomagnesemia in cancer patients. Biomed Pharmacol 1991; 45: 315–7.

Ashby JP Newman DJ Rinsler MG . Is intact PTH a sensitive biochemical indicator of deranged calcium homeostasis in Vitamin D deficiency? Ann Clin Biochem 1989; 26: 324–7.

Lips P . Vitamin D deficiency and osteoporosis; the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest 1996; 26: 436–42.

Rude RK Oldham SB Singer FR . Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol 1976; 5: 209–24.

Mayne PD Kovar IZ . Calcium and phosphorus metabolism in the premature infant. Ann Clin Biochem 1991; 28: 131–42.

Hillman LS Haddad JG . Hypocalcaemia and other abnormalities of mineral homeostatsis during the neonatal period. In: Heath DA Marx SJ , eds. Calcium Disorders. London: Butterworth Scientific, 1982: 248–76.

Ott SM Maloney NA Coburn JW Alfrey AC Sherrard DJ . The prevalence of bone aluminium deposition in renal osteodystrophy and its relation to the response to calcitriol. N Engl J Med 1982; 307: 709–13.

Felsenfield AJ Llach F . Parathyroid gland function in chronic renal failure. Kidney Int 1993; 43: 771–89.

Hercz G Pei C Greenwood A Manuel A Saiphoo C Goodman WG . Aplastic osteodystrophy without aluminium: The role of “suppressed” parathyroid function. Kidney Int 1993; 44: 860–6.

Andress DL Endres DB Maloney NA Kopp JB Coburn JW Sherrard DJ . Comparison of parathyroid assays with bone histomorphometry in renal osteodystrophy. J Clin Endocrinol Metab 1986; 63: 1163–9.

Morita A Tabata T Koyama H Emoto M Inoue T Miki T . A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in haemodialysis patients. Clin Nephrol 1992; 38: 154–7.

Saha H Pietila K Mustonen J Pasternack A Morsky P . Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in haemodialysis patients. Clin Nephrol 1992; 38: 145–8.

Quarles LD Lobough B Murphy G . Intact parathyroid hormone over-estimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75: 145–50.

Hutchison AJ Whitehouse RW Boulton HF Adams JE Mawer EB Freemont TJ . Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071–7.

Salusky IB Ramirez JA Oppenheim W Gales B Segre GV Goodman WG . Biochemical markers of renal oteodystrophy in paediatric patients undergoing CAPD/CCPD. Kidney Int 1994; 45: 253–8.

Gladziwa U Ittel TH Dakshinamurty KV Schacht B Riehl J Sieberth HG . Secondary hyperparathyroidism and sonographic evaluation of parathyroid gland hyperplasia in dialysis patients. Clin Nephrol 1992; 38: 162–6.

Tibi L Chhabra SC Sweeting VM Winney RJ Smith AF . Mutiple forms of alkaline phosphatase in plasma of haemodialysis patients. Clin Chem 1991; 37: 815–20.

Andress DL Norris KC Coburn JW Slatopolsky EA Sherrard DJ . Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 1989; 321: 274–9.

Hutchison AJ Freemont AJ Boulton HF Gokal R . Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia. Nephrol Dial Transplant 1992; 7: 1219–25.

Coen G Mazzaferro S Ballanti P Bonucci E Cinotti GA Fondi G . Two-site immunometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure. J Lab Clin Med 1993; 122: 103–9.